| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.089 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |